# A Study to Investigate Tonlamarsen for the Treatment of Adults With Uncontrolled Hypertension (KARDINAL)

Study · id `cardio:ct-nct06864104` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06864104](<https://clinicaltrials.gov/study/NCT06864104>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06864104

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 206 participants.

## Technical summary

Registry record NCT06864104. Randomized; quadruple masking; primary purpose treatment. Start 2025-04-10 (actual); primary completion 2026-01-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 206 participants (enrolled count; ClinicalTrials.gov record NCT06864104, source copy `cardio:ctgov-nct06864104-2026-03-31`, retrieved 2026-11-18)
- Started: 2025-04-10 (actual) (ClinicalTrials.gov record NCT06864104, source copy `cardio:ctgov-nct06864104-2026-03-31`, retrieved 2026-11-18)
- Primary completion: 2026-01-12 (actual) (ClinicalTrials.gov record NCT06864104, source copy `cardio:ctgov-nct06864104-2026-03-31`, retrieved 2026-11-18)
- Completion: 2026-03-17 (actual) (ClinicalTrials.gov record NCT06864104, source copy `cardio:ctgov-nct06864104-2026-03-31`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT06864104, source copy `cardio:ctgov-nct06864104-2026-03-31`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06864104-2026-03-31`, retrieved 2026-11-18)

## The registry's words

- Brief title: A Study to Investigate Tonlamarsen for the Treatment of Adults With Uncontrolled Hypertension (KARDINAL)
- Condition: Hypertension
- Intervention (Drug): Tonlamarsen
- Intervention (Drug): Placebo
- Lead sponsor: Kardigan, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Kardigan, Inc. (`cardio:org-kardigan-inc`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy of Tonlamarsen in Patients With Uncontrolled Hypertension: The KARDINAL Phase 2 Randomized Clinical Trial (`cardio:pubmed-41949512`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 52eb9d60eeb99e95aa386883644ea046ee31ee21e0818cc8c4e3615276606eb7
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
